Financials

  • Market Capitalization 1.91 B
  • Employee 367
  • Founded 2016
  • CEO Marianne De Backer
  • Website www.vir.bio
  • Headquarter Delaware, United States
  • FIGI BBG00H2QQ8T5
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.91
Fiyat/satışlar oranı
12.18

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2004
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
34.28 USD+0.85%+1.48%-4.33%-21.00%2.05 B USD
2040
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.96 USD-1.00%-3.56%+10.17%+109.86%1.94 B USD
2055
IMCR
Immunocore Holdings plc - American Depositary Shares
36.75 USD-1.00%+0.14%+10.00%+9.77%1.89 B USD
2056
SEPN
Septerna, Inc. - Common Stock
40.47 USD+0.55%-2.34%+19.13%+83.87%1.89 B USD

Haberler